US coalition develops templates to check melamine contamination
This article was originally published in SRA
Executive Summary
A coalition of US pharmaceutical industry associations has developed a set of standard templates that drug companies can use to get feedback on the material controls that their suppliers and contract manufacturers have in place to prevent melamine contamination of raw materials1-4.